Healthcare Industry News: PEEK
News Release - March 15, 2010
Integra LifeSciences Introduces Four New Products at the Association of periOperative Registered Nurses (AORN) ConferencePLAINSBORO, N.J., March 15, 2010 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences (Nasdaq:IART ) introduced four new products today at the AORN conference in Denver, Colorado. The products include Secure-Cut(TM) Reposable Endoscopic Scissors, Ruggles(TM) Bayonet Curettes, Jarit(R) Disposable Bi-polar Forceps, and an improved LumbarTrak(TM) retraction system.
Secure-Cut(TM) reposable scissors are composed of a cost effective reusable carbon fiber handle with a PEEK shaft and "always sharp" single use scissor tips. The system includes a secure connection comprised of stainless steel threading that ensures a robust, lasting connection; and a protective PEEK insulation that prevents arcing. Surgeons expect their scissors to be sharp, and the Secure-CutTM system gives them the confidence that they'll have a sharp, new cut every time.
The Ruggles(TM) Bayonet Curettes allow spine surgeons to see the operative field more clearly by providing an offset handle. The new line of Ruggles(TM) Curettes complements Integra's already comprehensive array of neuro/spine instruments.
Integra's improved LumbarTrak(TM) retractor system incorporates enhancements to the frame that provide unparalleled strength. Since minutes matter in the operating room, the LumbarTrak(TM) retractor system is designed to help surgeons establish prompt and lasting exposure during their lumbar spine procedures.
Finally, the new Jarit(R) Disposable Bi-polar Forceps deliver gentle coagulation between highly polished instrument tips to minimize coagulum adhesion. This important addition to Integra's forceps portfolio complements its Buzz(TM) reusable non-stick forceps.
"We realize that minutes matter in the operating room, and that the busiest surgeons expect us to help them minimize uncertainty within their procedures," said Dan Reuvers, Vice President of Marketing and Product Development for Integra Surgical. "Each of these new instruments is designed to provide surgeons with added confidence, ensuring they have the most dependable tools available."
Integra Surgical's direct sales organization and distributor network will sell the four new surgical instruments. Integra Surgical is a leading provider of Jarit(R) brand surgical instruments, used in general, neurosurgery, cardiac surgery and most other surgical modalities, the Omni-Tract(R) family of retractor systems, and the LUXTEC(R) illumination products. For more information, visit http://www.integra-surgical.com/.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients every year. The company's products are used primarily in orthopedics, neurosurgery and general surgery. Headquartered in Plainsboro, New Jersey, Integra has research and manufacturing facilities throughout the world. For more information, visit http://www.integra-ls.com.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning the future use of Integra products. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, the willingness of physicians to use these products may affect the prospects for their use in clinical procedures. In addition, the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in Item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2009 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.
Source: Integra LifeSciences
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.